Fidia S.p.A. (BIT:FDA)
0.2781
-0.0049 (-1.73%)
Aug 14, 2025, 2:41 PM CET
Fidia Revenue
In the year 2024, Fidia had annual revenue of 17.53M EUR, down -38.98%. Fidia had revenue of 8.11M in the half year ending December 31, 2024, a decrease of -46.72%.
Revenue
17.53M
Revenue Growth
-38.98%
P/S Ratio
0.12
Revenue / Employee
110.28K
Employees
159
Market Cap
2.11M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.53M | -11.20M | -38.98% |
Dec 31, 2023 | 28.74M | 4.07M | 16.52% |
Dec 31, 2022 | 24.66M | 485.00K | 2.01% |
Dec 31, 2021 | 24.18M | 2.52M | 11.65% |
Dec 31, 2020 | 21.65M | -24.55M | -53.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Leonardo S.p.a. | 18.70B |
Poste Italiane | 13.75B |
Prysmian | 18.98B |
Fincantieri | 8.85B |
Iveco Group | 14.81B |
Interpump Group | 2.06B |
Webuild | 12.30B |
Maire | 6.65B |
Fidia News
- 1 hour ago - Beam gains FDA Regenerative Medicine Advanced Therapy status for sickle cell treatment - Seeking Alpha
- 2 hours ago - Whoop CEO Will Ahmed on FDA warning: Our blood pressure insight is intended for wellness use only - CNBC
- 3 hours ago - FDA eyes warning label for antidepressants during pregnancy - The Hill
- 8 hours ago - Press Release: Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease - Benzinga
- 13 hours ago - Hyperfine targets 10–20% revenue growth for 2025 following FDA clearances and next-gen Swoop system launch - Seeking Alpha
- 15 hours ago - FDA considers revoking Pfizer COVID vaccine for children under 5 - The Hill
- 15 hours ago - Insmed CEO on whats next for company after FDA greenlights lung disease drug - CNBC
- 16 hours ago - HeartBeam Cuts Costs Awaits FDA Decision - The Motley Fool